Hot Pursuit     02-Jan-24
Biocon Ltd soars 3.74%, rises for third straight session
Biocon Ltd is quoting at Rs 265.1, up 3.74% on the day as on 12:49 IST on the NSE. The stock is up 0.65% in last one year as compared to a 18.64% gain in NIFTY and a 36.1% gain in the Nifty Pharma index.

Biocon Ltd is up for a third straight session in a row. The stock is quoting at Rs 265.1, up 3.74% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.51% on the day, quoting at 21632. The Sensex is at 71811.63, down 0.64%. Biocon Ltd has risen around 10.16% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has risen around 6.02% in last one month and is currently quoting at 16858.75, up 2.06% on the day. The volume in the stock stood at 121.81 lakh shares today, compared to the daily average of 36.37 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 266.2, up 3.4% on the day. Biocon Ltd is up 0.65% in last one year as compared to a 18.64% gain in NIFTY and a 36.1% gain in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending September 23.

Previous News
  Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'
 ( Hot Pursuit - 27-Jun-25   12:18 )
  Biocon raises Rs 4,500 crore via QIP
 ( Hot Pursuit - 21-Jun-25   09:13 )
  Restaurant Brands Asia Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Jun-25   12:00 )
  Biocon get facilities rated
 ( Corporate News - 18-Jun-25   09:41 )
  Indices drift lower in early trade; breadth positive
 ( Market Commentary - Mid-Session 17-Jun-25   09:37 )
  Biocon Ltd soars 3.52%, Gains for third straight session
 ( Hot Pursuit - 11-Jun-25   13:05 )
  Biocon gets CDSCO approval for Liraglutide drug substance
 ( Hot Pursuit - 03-Jun-25   08:23 )
  Biocon Biologics announces extension of insulin supply agreement with Govt. of Malaysia
 ( Corporate News - 22-May-25   09:19 )
  Biocon Ltd spurts 1.3%, up for five straight sessions
 ( Hot Pursuit - 19-May-25   13:00 )
  Biocon's subsidiary get US FDA nod for anticoagulant medication Rivaroxaban
 ( Hot Pursuit - 16-May-25   09:38 )
  Biocon
 ( Results - Analysis 09-May-25   10:36 )
Other Stories
  Bharat Forge gains after acquiring AAM India manufacturing
  02-Jul-25   15:15
  NBCC (India) secures Rs 355 crore PMC contract for Gorewada Zoo Project
  02-Jul-25   15:01
  Jindal Worldwide Ltd leads losers in 'A' group
  02-Jul-25   15:00
  Sigachi Industries Ltd leads losers in 'B' group
  02-Jul-25   14:45
  Volumes spurt at Rites Ltd counter
  02-Jul-25   14:30
  Tamilnad Mercantile Bank total deposits jump 9% YoY to Rs 53,803 cr in June’25
  02-Jul-25   14:30
  United Spirits Ltd down for fifth straight session
  02-Jul-25   13:35
  Oracle Financial Services Software Ltd eases for fifth straight session
  02-Jul-25   13:35
  Dr Reddys Laboratories Ltd slips for fifth straight session
  02-Jul-25   13:35
  Dev IT gains on securing Rs 4-cr orders from Alivus Lifesciences
  02-Jul-25   13:12
Back Top